Description

BSE circular containing clarifications from Yasho Industries Limited, Aarti Pharmalabs Limited, and AI Champdany Industries Limited regarding volume movements and price behavior in their securities.

Summary

BSE issued a circular containing clarifications from three companies—Yasho Industries Limited (Scrip Code: 541167), Aarti Pharmalabs Limited (Scrip Code: 543748), and AI Champdany Industries Limited—in response to BSE Surveillance queries regarding significant increases in trading volumes and price movements of their securities. All companies confirmed they have made all necessary disclosures under Regulation 30 of SEBI LODR Regulations, 2015, have no undisclosed material information, and stated that the price/volume movements are purely market driven.

Key Points

  • Yasho Industries Limited clarified that all material information has been disclosed promptly under Regulation 30 of SEBI LODR Regulations
  • Company management is not connected with any increase in price/volume of the scrip
  • Aarti Pharmalabs Limited confirmed timely dissemination of all required information to stock exchanges
  • No pending announcements or undisclosed information that may affect price or volume behavior
  • All companies stated that volume/price movements are absolutely market driven and not due to any undisclosed material events
  • AI Champdany Industries Limited response was included but content was truncated in the source document

Regulatory Changes

No regulatory changes announced. This circular is a disclosure of routine surveillance responses.

Compliance Requirements

  • Companies are required to respond to BSE Surveillance queries regarding unusual price/volume movements
  • Companies must confirm compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
  • Companies must disclose if there is any undisclosed material information that could impact price/volume behavior

Important Dates

  • January 12, 2026: Date of clarifications from companies
  • January 12, 2026: Date of BSE Surveillance queries (Ref No. L/SURV/ONL/PV/APJ/2025-2026/862 for Yasho Industries and Ref No. L/SURV/ONL/PV/APJ/2025-2026/859 for Aarti Pharmalabs)

Impact Assessment

Minimal market impact. These are routine surveillance clarifications confirming that companies have complied with disclosure norms and that recent price/volume movements are market driven rather than due to undisclosed material events. Investors should note that BSE actively monitors unusual trading patterns and seeks timely clarifications from listed entities. The responses provide transparency but do not indicate any new material information or corporate actions.

Impact Justification

Routine surveillance clarifications from companies stating no undisclosed material information and confirming price/volume movements are market driven